Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

June 1, 2021; Volume 62,Issue 6

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine June 1, 2021, 62 (6) 14A;

Discussions with Leaders

  • You have access
    Industry Perspective on the Changing Nuclear Medicine Landscape
    Jonathan Allis and David Mankoff
    Journal of Nuclear Medicine June 1, 2021, 62 (6) 749-751; DOI: https://doi.org/10.2967/jnumed.121.262338

The State of the Art

  • You have access
    The T.R.U.E. Checklist for Identifying Impactful Artificial Intelligence–Based Findings in Nuclear Medicine: Is It True? Is It Reproducible? Is It Useful? Is It Explainable?
    Irène Buvat and Fanny Orlhac
    Journal of Nuclear Medicine June 1, 2021, 62 (6) 752-754; DOI: https://doi.org/10.2967/jnumed.120.261586

Hot Topics

  • You have access
    The Australasian Radiopharmaceutical Trials Network: Clinical Trials, Evidence, and Opportunity
    Roslyn J. Francis, Dale L. Bailey, Michael S. Hofman and Andrew M. Scott
    Journal of Nuclear Medicine June 1, 2021, 62 (6) 755-756; DOI: https://doi.org/10.2967/jnumed.120.258152

Continuing Education

  • You have access
    Fundamental Statistical Concepts in Clinical Trials and Diagnostic Testing
    Stephanie L. Pugh and Pedro A. Torres-Saavedra
    Journal of Nuclear Medicine June 1, 2021, 62 (6) 757-764; DOI: https://doi.org/10.2967/jnumed.120.245654

Focus on Molecular Imaging

  • You have access
    Molecular Imaging: PARP-1 and Beyond
    Laura N. Puentes, Mehran Makvandi and Robert H. Mach
    Journal of Nuclear Medicine June 1, 2021, 62 (6) 765-770; DOI: https://doi.org/10.2967/jnumed.120.243287

Editorial

  • You have access
    Governments Are Constitutionally Permitted to Provide “Vaccine Passports”—Some May Also Be Constitutionally Obligated to Do So
    Kevin Cope and Alexander Stremitzer
    Journal of Nuclear Medicine June 1, 2021, 62 (6) 771-772; DOI: https://doi.org/10.2967/jnumed.121.262434

Oncology

  • Clinical

    • You have access
      Dynamic 68Ga-PSMA-11 PET/CT for the Primary Evaluation of Localized Renal Mass: A Prospective Study
      Shay Golan, Tzach Aviv, David Groshar, Maxim Yakimov, Yaniv Zohar, Yoad Prokocimer, Andrei Nadu, Jack Baniel, Liran Domachevsky and Hanna Bernstine
      Journal of Nuclear Medicine June 1, 2021, 62 (6) 773-778; DOI: https://doi.org/10.2967/jnumed.120.251272
    • FEATURED ARTICLE OF THE MONTH

      • Impact of <sup>68</sup>Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas
        You have access
        Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas
        Manuel Röhrich, Patrick Naumann, Frederik L. Giesel, Peter L. Choyke, Fabian Staudinger, Annika Wefers, Dawn P. Liew, Clemens Kratochwil, Hendrik Rathke, Jakob Liermann, Klaus Herfarth, Dirk Jäger, Jürgen Debus, Uwe Haberkorn, Matthias Lang and Stefan A. Koerber
        Journal of Nuclear Medicine June 1, 2021, 62 (6) 779-786; DOI: https://doi.org/10.2967/jnumed.120.253062
    • You have access
      A Phase 1 and Biodistribution Study of ABT-806i, an 111In-Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806
      Hui K. Gan, Matthew Burge, Benjamin Solomon, Sze Ting Lee, Kyle D. Holen, Yumin Zhang, Marika Ciprotti, F.T. Lee, Wijith Munasinghe, JuDee Fischer, Peter Ansell, Gerard Fox, Hao Xiong, Edward B. Reilly, Rod Humerickhouse and Andrew M. Scott
      Journal of Nuclear Medicine June 1, 2021, 62 (6) 787-794; DOI: https://doi.org/10.2967/jnumed.120.253146
  • Basic

    • Comparison of CD38-Targeted α- Versus β-Radionuclide Therapy of Disseminated Multiple Myeloma in an Animal Model
      You have access
      Comparison of CD38-Targeted α- Versus β-Radionuclide Therapy of Disseminated Multiple Myeloma in an Animal Model
      Megan Minnix, Vikram Adhikarla, Enrico Caserta, Erasmus Poku, Russell Rockne, John E. Shively and Flavia Pichiorri
      Journal of Nuclear Medicine June 1, 2021, 62 (6) 795-801; DOI: https://doi.org/10.2967/jnumed.120.251983
    • You have access
      18F-AraG PET for CD8 Profiling of Tumors and Assessment of Immunomodulation by Chemotherapy
      Jelena Levi, Samuel Goth, Lyna Huynh, Tina Lam, Tony L. Huynh, Brailee Schulte and Juliet A. Packiasamy
      Journal of Nuclear Medicine June 1, 2021, 62 (6) 802-807; DOI: https://doi.org/10.2967/jnumed.120.249078

Theranostics

  • Clinical

    • You have access
      18F-FDG PET is Superior to WHO Grading as a Prognostic Tool in Neuroendocrine Neoplasms and Useful in Guiding PRRT: A Prospective 10-Year Follow-up Study
      Tina Binderup, Ulrich Knigge, Camilla Bardram Johnbeck, Annika Loft, Anne Kiil Berthelsen, Peter Oturai, Jann Mortensen, Birgitte Federspiel, Seppo W. Langer and Andreas Kjaer
      Journal of Nuclear Medicine June 1, 2021, 62 (6) 808-815; DOI: https://doi.org/10.2967/jnumed.120.244798
    • You have access
      A Rapid and Safe Infusion Protocol for 177Lu Peptide Receptor Radionuclide Therapy
      Sander C. Ebbers, Maarten W. Barentsz, Bart de Keizer, Gerard C. Krijger, Marnix G.E.H. Lam and Arthur J.A.T. Braat
      Journal of Nuclear Medicine June 1, 2021, 62 (6) 816-822; DOI: https://doi.org/10.2967/jnumed.120.252494
    • You have access
      Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network
      Dejan Kostyszyn, Tobias Fechter, Nico Bartl, Anca L. Grosu, Christian Gratzke, August Sigle, Michael Mix, Juri Ruf, Thomas F. Fassbender, Selina Kiefer, Alisa S. Bettermann, Nils H. Nicolay, Simon Spohn, Maria U. Kramer, Peter Bronsert, Hongqian Guo, Xuefeng Qiu, Feng Wang, Christoph Henkenberens, Rudolf A. Werner, Dimos Baltas, Philipp T. Meyer, Thorsten Derlin, Mengxia Chen and Constantinos Zamboglou
      Journal of Nuclear Medicine June 1, 2021, 62 (6) 823-828; DOI: https://doi.org/10.2967/jnumed.120.254623
    • Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with <sup>67</sup>Cu
      You have access
      Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with 67Cu
      Lachlan E. McInnes, Carleen Cullinane, Peter D. Roselt, Susan Jackson, Benjamin J. Blyth, Ellen M. van Dam, Nicholas A. Zia, Matthew J. Harris, Rodney J. Hicks and Paul S. Donnelly
      Journal of Nuclear Medicine June 1, 2021, 62 (6) 829-832; DOI: https://doi.org/10.2967/jnumed.120.251579

Endocrinology

  • Clinical

    • You have access
      Imaging of the Glucagon Receptor in Subjects with Type 2 Diabetes
      Olof Eriksson, Irina Velikyan, Torsten Haack, Martin Bossart, Iina Laitinen, Philip J. Larsen, Jan Erik Berglund, Gunnar Antoni, Lars Johansson, Stefan Pierrou, Joachim Tillner and Michael Wagner
      Journal of Nuclear Medicine June 1, 2021, 62 (6) 833-838; DOI: https://doi.org/10.2967/jnumed.118.213306
  • Basic

    • FEATURED BASIC SCIENCE ARTICLE

      • Optoacoustic Imaging of Glucagon-like Peptide-1 Receptor with a Near-Infrared Exendin-4 Analog
        You have access
        Optoacoustic Imaging of Glucagon-like Peptide-1 Receptor with a Near-Infrared Exendin-4 Analog
        Sheryl Roberts, Eshita Khera, Crystal Choi, Tejas Navaratna, Jan Grimm, Greg M. Thurber and Thomas Reiner
        Journal of Nuclear Medicine June 1, 2021, 62 (6) 839-848; DOI: https://doi.org/10.2967/jnumed.120.252262

Cardiovascular

  • Clinical

    • Diagnostic Performance of PET Versus SPECT Myocardial Perfusion Imaging in Patients with Smaller Left Ventricles: A Substudy of the <sup>18</sup>F-Flurpiridaz Phase III Clinical Trial
      You have access
      Diagnostic Performance of PET Versus SPECT Myocardial Perfusion Imaging in Patients with Smaller Left Ventricles: A Substudy of the 18F-Flurpiridaz Phase III Clinical Trial
      René R. Sevag Packard, Joel L. Lazewatsky, Cesare Orlandi and Jamshid Maddahi
      Journal of Nuclear Medicine June 1, 2021, 62 (6) 849-854; DOI: https://doi.org/10.2967/jnumed.120.252007

Neurology

  • Clinical

    • You have access
      Principal-Component Analysis–Based Measures of PET Data Closely Reflect Neuropathologic Staging Schemes
      Ganna Blazhenets, Lars Frings, Arnd Sörensen and Philipp T. Meyer; for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine June 1, 2021, 62 (6) 855-860; DOI: https://doi.org/10.2967/jnumed.120.252783

Physics and Instrumentation

  • Basic

    • Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View
      You have access
      Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View
      Benjamin A. Spencer, Eric Berg, Jeffrey P. Schmall, Negar Omidvari, Edwin K. Leung, Yasser G. Abdelhafez, Songsong Tang, Zilin Deng, Yun Dong, Yang Lv, Jun Bao, Weiping Liu, Hongdi Li, Terry Jones, Ramsey D. Badawi and Simon R. Cherry
      Journal of Nuclear Medicine June 1, 2021, 62 (6) 861-870; DOI: https://doi.org/10.2967/jnumed.120.250597

AI/Advanced Image Analysis

  • Translational

    • Conditional Generative Adversarial Networks Aided Motion Correction of Dynamic <sup>18</sup>F-FDG PET Brain Studies
      Open Access
      Conditional Generative Adversarial Networks Aided Motion Correction of Dynamic 18F-FDG PET Brain Studies
      Lalith Kumar Shiyam Sundar, David Iommi, Otto Muzik, Zacharias Chalampalakis, Eva-Maria Klebermass, Marius Hienert, Lucas Rischka, Rupert Lanzenberger, Andreas Hahn, Ekaterina Pataraia, Tatjana Traub-Weidinger, Johann Hummel and Thomas Beyer
      Journal of Nuclear Medicine June 1, 2021, 62 (6) 871-879; DOI: https://doi.org/10.2967/jnumed.120.248856

Letters to the Editor

  • You have access
    Theragnostics: A Neologism That Generates Schism—The Hellenic Thesis
    Savvas Frangos, Evanthia Giannoula, John Buscombe and Ioannis Iakovou
    Journal of Nuclear Medicine June 1, 2021, 62 (6) 880; DOI: https://doi.org/10.2967/jnumed.121.262101

SNMMI Newsline

  • You have access
    SNMMI Newsline
    Journal of Nuclear Medicine June 1, 2021, 62 (6) 23N-34N;
  • You have access
    Status of Nuclear Medicine in Latin America and the Caribbean: IAEA Analysis of Development in the Past 6 Years
    Pilar Orellana, Fernando Mut, Enrique Estrada, Miriam Mikhail Lette, Olivier Pellet, Olga Morozova, Noura El-Haj, Juan C. Bucheli, Yaroslav Pynda, Tetiana Okolielova, Ariadna Cherit, Francesco Giammarile and Diana Paez
    Journal of Nuclear Medicine June 1, 2021, 62 (6) 23N-29N;
  • You have access
    SNMMI Statement: The Effect of COVID-19 Vaccination on FDG PET/CT
    Journal of Nuclear Medicine June 1, 2021, 62 (6) 30N;
  • You have access
    SNMMI Fellowships for NCTN Cooperative Group Participation
    Journal of Nuclear Medicine June 1, 2021, 62 (6) 30N;
  • You have access
    From the ABNM: Adoption of Progressive Leave Policy for Residents and Fellows
    Leonie Gordon
    Journal of Nuclear Medicine June 1, 2021, 62 (6) 31N;
  • You have access
    A Challenging and Rewarding Year
    Alan B. Packard
    Journal of Nuclear Medicine June 1, 2021, 62 (6) 32N;
  • You have access
    From the Literature
    Journal of Nuclear Medicine June 1, 2021, 62 (6) 33N-34N;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 62 (6)
Journal of Nuclear Medicine
Vol. 62, Issue 6
June 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas
  • Optoacoustic Imaging of Glucagon-like Peptide-1 Receptor with a Near-Infrared Exendin-4 Analog
Sign up for alerts

Jump to

  • This Month in JNM
  • Discussions with Leaders
  • The State of the Art
  • Hot Topics
  • Continuing Education
  • Focus on Molecular Imaging
  • Editorial
  • Oncology
    • Clinical
      • FEATURED ARTICLE OF THE MONTH
    • Basic
  • Theranostics
    • Clinical
  • Endocrinology
    • Clinical
    • Basic
      • FEATURED BASIC SCIENCE ARTICLE
  • Cardiovascular
    • Clinical
  • Neurology
    • Clinical
  • Physics and Instrumentation
    • Basic
  • AI/Advanced Image Analysis
    • Translational
  • Letters to the Editor
  • SNMMI Newsline
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire